维普中文期刊产品整合服务
19篇 您的检索式:作者名="CHRISTIAN W V"
    题名 作者 年代 出处 被引量
1Retrospective study on mixed neuroendocrine non-neuroendocrine neoplasms from five European centres显示文摘BACKGROUND Mixed neuroendocrine non-neuroendocrine neoplasm(MiNEN)is a rare diagnosis,mainly encountered in the gastro-entero-pancreatic tract.There is limited knowledge of its epidemiology,prognosis and biology,and the best management for affected patients is still to be defined.AIM To investigate clinical-pathological characteristics,treatment modalities and survival outcomes of a retrospective cohort of patients with a diagnosis of MiNEN.METHODS Consecutive patients with a histologically proven diagnosis of MiNEN were identified at 5 European centres.Patient data were retrospectively collected from medical records.Pathological samples were reviewed to ascertain compliance with the 2017 World Health Organisation definition of MiNEN.Tumour responses to systemic treatment were assessed according to the Response Evaluation Criteria in Solid Tumours 1.1.Kaplan-Meier analysis was applied to estimate survival outcomes.Associations between clinical-pathological characteristics and survival outcomes were explored using Log-rank test for equality of survivors functions(univariate)and Cox-regression analysis(multivariable).RESULTS Sixty-nine consecutive patients identified;Median age at diagnosis:64 years.Males:63.8%.Localised disease(curable):53.6%.Commonest sites of origin:colon-rectum(43.5%)and oesophagus/oesophagogastric junction(15.9%).The neuroendocrine component was;predominant in 58.6%,poorly differentiated in 86.3%,and large cell in 81.25%,of cases analysed.Most distant metastases analysed(73.4%)were occupied only by a poorly differentiated neuroendocrine component.Ninety-four percent of patients with localised disease underwent curative surgery;53%also received perioperative treatment,most often in line with protocols for adenocarcinomas from the same sites of origin.Chemotherapy was offered to most patients(68.1%)with advanced disease,and followed protocols for pure neuroendocrine carcinomas or adenocarcinomas in equal proportion.In localised cases,median recurrence free survival(RFS);14.0 months(95%CI:9.2-24.4),and median overall survival(OS):28.6 months(95%CI:18.3-41.1).On univariate analysis,receipt of perioperative treatment(vs surgery alone)did not improve RFS(P=0.375),or OS(P=0.240).In advanced cases,median progression free survival(PFS);5.6 months(95%CI:4.4-7.4),and median OS;9.0 months(95%CI:5.2-13.4).On univariate analysis,receipt of palliative active treatment(vs best supportive care)prolonged PFS and OS(both,P<0.001).CONCLUSION MiNEN is most commonly driven by a poorly differentiated neuroendocrine component,and has poor prognosis.Advances in its biological understanding are needed to identify effective treatments and improve patient outcomes.Melissa Frizziero Xin Wang Bipasha Chakrabarty Alexa Childs Tu V Luong Thomas Walter Mohid S Khan Meleri Morgan Adam Christian Mona Elshafie Tahir Shah Annamaria Minicozzi Wasat Mansoor Tim Meyer Angela Lamarca Richard A Hubner Juan W Valle Mairéad G McNamara 2019World Journal of Gastroenterology2019,25,39:13
2Toxicodynamic therapeutic drug monitoring of immunosuppressants: promises, reality, and challenges显示文摘Christians U Schmitz V Schoning W 2008Ther Drug Monit2008,30,2:1
3Lithium incorporation by V6O13 and related vanadium (+4, +5) oxide cathode materials显示文摘MURPHY D W CHRISTIAN P A DISALVO F J CARIDES J N WASZCZAK J V 1981J Electrochemical Society1981,128,10:1
4Lithium incorporation by vanadium pentoxide显示文摘MURPHY D W CHRISTIAN P A DISALVO F J WASZCZAK J V 1979Inorg Chem1979,18,:1
5High white blood cell count is associated with a worsening of insulin sensitivity and predicts the development of type 2 diabetes显示文摘BARBORA V CHRISTIAN W ROBERT S 2002Diabetes2002,51,2:1
6OSTalpha-OSTbeta:a major basolateral bile acid and steroid transporter in human intestinal,renal,and biliary epithelia显示文摘 CHRISTIAN W V LEE J Y 2005Hepatology2005,42,6:1
7Activation of AP-1 and nuclear factor-kappaB transcription factors is involved in hydrogen peroxide-induced apoptotic cell death of oligodendroytes 显示文摘Ulrich V Michal W Christiane RL 1999Journal of Neurochemistry1999,73,6:1
8Coordinating supplier involvement in product development projects: a differentiated coordination typology 显示文摘NICOLETTE L CHRISTIAN B ARJAN V W 2006R&D Management2006,,1:1
9N - terminal pro - B - type natriuretic peptide levels for dynamic risk stratification of patients with acute coronary syndromes 显示文摘Heechen C Christian W Mitrovic V et 81 2004Circulation2004,110,20:1
10Toxicodynamic therapeutic drug monitoring of immunosuppressants: promises, reality, and challenges显示文摘Christians U Schmitz V Sch?ning W Bendrick-Peart J Klawitter J Haschke M 2008Ther Drug Monit2008,30,2:1
11Toxieodynamic thera- peutic drog monitoring of immunosuppressants : promises, reality,and challenges显示文摘Christians U Sehmitz V Schning W 2008Ther Drug Monit2008,30,2:1
12Assessment of potential impacts of agricultural practices on the environment: the AGRO*ECO method显示文摘Philippe G Christian B Hayo V W 2000Environmental Assessment Review2000,20,:1
13Associated with a worsening ofinsulin sensitivity and predicts the development of type 2 diabetes显示文摘Barbora V Christian W Robert S 2002Diabetes2002,5,2:1
14Platelets as immune cells bridging inflammation and cardiovascular disease 显示文摘Philipp v H Christian W 2007Circulation Research2007,5,19:1
15The treat- ment of patients with HIV 显示文摘Martin V Sehwarze Zander C Christian W 2010Dtseh Arzteblint2010,107,28:1
16The treat- ment of patients with HIV显示文摘Martin V Schwarze - zander C Jan - Christian W 2010Dtsch Arzteblint2010,107,2829:1
17Supporting taskoriented modeling using interactive UML views 显示文摘Christian F J L Martiin A M W Michel R V C 2005Journal of Visual Languages and Computing2005,18,4:1
18High white blood cell count is associated with a worsening of insulin sensitivity and predicts the development of type 2 diabetes 显示文摘Barbora V Christian W Robert SL 2002Diabetes2002,51,2:1
19Toxicodynamic therapeutic drug monitoring of immunosuppressants:promises,reality and challenges显示文摘CHRISTIANS U SCHMITZ V SCH?NING W 2008Ther Drug Monit2008,30,2:1
返回顶部 每页显示:
共1页 首页 上一页 第1页 下一页 末页 /1 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费